Question:
Pertuzumab (Perjeta)
Author: Natalia AbesadaAnswer:
Anti HER2. Traitement neoadjuvant du cancer du sein. Se lie au domain 2 extracellulaire du RHER2.
0 / 5 Â (0 ratings)
1 answer(s) in total
Author
Natalia Abesada
Answer:
0 / 5 Â (0 ratings)
1 answer(s) in total